TechNavio today launched its report Global Ovarian Cancer Drugs Market 2011-2015 based on an in-depth study covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers’ understanding of the present and future landscape of the market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said; ”The current trend witnessed by the Global Ovarian Cancer Drugs market is the use of combination therapies for the treatment of ovarian cancer. Several oncologists believe that chemotherapy drugs are most effective when given in combination with radiation therapy and surgery. Cancer cells that are confined locally can be easily treated by surgery or radiation therapy, while cancer cells that have spread to distant sites can be killed by chemotherapy. Therefore, combination therapies help in the complete removal of tumors and the destruction of cancerous cells. The combination is chosen according to the size of the tumor and the risk of recurrence.”
According to the report, globally, there has been an increase in the number of women being diagnosed with ovarian cancer. The increase in the prevalence of ovarian cancer is owing to a variety of factors such as obesity, infertility, mutations in specific genes, early start of menstruation, and late start of menopause. Furthermore, the incidence of ovarian cancer increases with the rapidly expanding elderly population. Thus, with the increase in the prevalence of ovarian cancer, the demand for ovarian cancer drugs is also increasing.
Further, the report also discusses that one of the major challenges for the Global Ovarian Cancer Drugs market is the patent expiry of key ovarian cancer drugs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic reports on niche and emerging technologies. For further information, please visit https://www.technavio.com/content/global-ovarian-cancer-drugs-market-2011…
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Report – Global Ovarian Cancer Drugs Market 2011-2015
